MedTrace Logo

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

NCT07075159 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-17

No results posted yet for this study

Summary

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Conditions

  • Wound Healing
  • Mohs Micrographic Surgery
  • Oculofacial Reconstruction

Interventions

DEVICE

Hydrocolloid Wound Dressing

one time hydrocolloid dressing application

Sponsors & Collaborators

  • Janice Hernandez, MD

    lead OTHER

Principal Investigators

  • Janice Hernandez, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2026-09-01
Completion
2026-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07075159 on ClinicalTrials.gov